Medansa Pharmaceuticals Private Limited
U51100DL2019PTC348400ActivePrivate · Non-govt companyRoC-DelhiUnlisted
Last updated: 2026-06-08
67
Compliance Health · C · provisional
3 / 4 signals passed
Medansa Pharmaceuticals Private Limited is a Private Non-govt company company incorporated in 2019 and based in Delhi, India. It was founded by Fauzia and Nigar. Medansa Pharmaceuticals Private Limited operates in Wholesale Trade (NIC 51100) with authorized capital of ₹10.00 L and paid-up capital of ₹3.00 L. For 2023-24, the company reported revenue of ₹18.10 L and a net loss of ₹64.7K. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Risk FlagsDirectors not yet extracted · awaiting MGT-7AGM 1727d ago · may be overdue
Revenue (latest FY)
₹18.10 L
2023-24
PAT (latest FY)
₹-64.7K
Margin -3.6%
Open Charges
0
No encumbrances
Active Directors
0
No resignations
Paid-up Capital
₹3.00 L
30% of authorized
Filings on Record
0
All current
Incorporated
2019
7 years old
State
Delhi
Sector
Wholesale Trade
NIC 51100
Class
Private
Sub-category
Non-govt company
Authorized Capital
₹10.00 L
Paid-up Capital
₹3.00 L
30% utilized
Members
—
Last AGM
19 Nov 2021
1727d ago
Last Balance Sheet
31 Mar 2021
1960d ago
Latest Filing
—
Registered Email
m************(at)gmail.com
Registered Office
H NO-80/3, HOUSE IN KH NO-200-A F/F NEW COLONY, CHANDAN HOLLA, NEAR PRIMARY SOUTH DELHI South Delhi DL 110074 IN
Quick facts
Registered office
H NO-80/3, HOUSE IN KH NO-200-A F/F NEW COLONY, CHANDAN HOLLA, NEAR PRIMARY SOUTH DELHI South Delhi DL 110074 IN
NIC code
51100
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
m************(at)gmail.com
Section
Wholesale Trade
ROC
RoC-Delhi
Website
—
Class · sub-category
Private · Non-govt company
Incorporation · Last AGM
05 Apr 2019 · 19 Nov 2021
Directors
LockedSI
Suresh Iyer
Director5.2y · Bengaluru · DIN 5182834
MK
Meera Krishnan
Director8.3y · Gurugram · DIN 5123144
PN
Priya Nair
Additional Director6.0y · Gurugram · DIN 3870728
Get the full board of directors
Directors, DINs & appointment history for Medansa Pharmaceuticals Private Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 23 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +20d | filed |
| MGT-7 | FY2023-24 | 20 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +27d | filed |
| MGT-7 | FY2022-23 | 26 Nov 2022 | 29 Nov 2022 | 0d | filed |
Get financial statements & other filing documents
Full MCA filing history for Medansa Pharmaceuticals Private Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 183205034 | Kotak Mahindra Bank Ltd(Bank) | ₹12.25 Cr | 27 Jan 2019 | Open |
| 481345222 | Kotak Mahindra Bank Ltd(Bank) | ₹1.19 Cr | 12 Mar 2023 | Open |
| 894200923 | Axis Bank Ltd(Bank) | ₹15.78 Cr | 19 Sep 2023 | Open |
| 869692111 | Axis Bank Ltd(Bank) | ₹1.10 Cr | 27 Jan 2021 | Open |
| 496842231 | Kotak Mahindra Bank Ltd(Bank) | ₹6.20 Cr | 04 Jul 2022 | Satisfied |
| 503593706 | HDFC Bank Ltd(Bank) | ₹12.63 Cr | 12 Mar 2019 | Open |
See registered charges & lenders
Charge IDs, lenders & amounts for Medansa Pharmaceuticals Private Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCARevenue (bars) vs PAT (line) by FY
Revenue PAT
| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2023-24 | — | ||||
| 2021-22 | — | ||||
| 2020-21 | — | ||||
| 2019-20 | — |
Detailed Financials
4 FYs| Line item | 2023-24 | 2021-22 | 2020-21 | 2019-20 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2023-24 | +56.0% | +477.0% | — | |
| Profit after Tax2023-24 | — | — | — | |
| Net Worth2023-24 | -16.0% | -94.0% | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2019-20 | -20.67% | — | -9.33% | -3.79% | 2.46 | |||
| 2020-21 | -5.33% | +476.86% | -16.32% | -5.89% | 2.77 | |||
| 2021-22 | -3.69% | +86.94% | -26.78% | -7.82% | 3.43 | |||
| 2023-24 | -3.57% | +35.41% | -76.37% | -13.11% | 5.83 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 2,80,94,149 | 75.39% |
| Institutional Investors | 2 | 8,75,966 | 2.35% |
| Public & Others | 37 | 82,95,245 | 22.26% |
See the full shareholding pattern
Promoter, institutional & public holding for Medansa Pharmaceuticals Private Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
500 peersMetricThis companyCohort medianCohort P75Quartile
Revenue (latest FY)
2nd quartile · P51
PAT (latest FY)
Bottom quartile · P18
Employees
—
—
—
—
Paid-up capital
2nd quartile · P73
Compliance Health
96
96
96
Bottom quartile · P9
Events & timeline
305 Apr 2019
Company incorporated
Medansa Pharmaceuticals Private Limited registered with RoC-Delhi; year 2019
05 Apr 2019
Fauzia appointed as Director
05 Apr 2019
Nigar appointed as Director
External data sources
7 plannedGSTIN Registrations
GST portal
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
MSME-1 form
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
AOC-4 schedule
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
CRISIL / ICRA / CARE feeds
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
IP India Trademark Registry
Applied, registered, opposed. Class numbers + status.
Patents
IP India Patent Registry
Applications and grants. Inventor names + filing dates.
Legal Cases
eCourts + Indian Kanoon
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.
FAQs about Medansa Pharmaceuticals Private Limited
When was Medansa Pharmaceuticals Private Limited incorporated?
Medansa Pharmaceuticals Private Limited was incorporated in 2019 (around 05 Apr 2019). Its CIN is U51100DL2019PTC348400 and it is registered with RoC-Delhi.
Where is Medansa Pharmaceuticals Private Limited located?
Medansa Pharmaceuticals Private Limited is headquartered in Delhi, at: H NO-80/3, HOUSE IN KH NO-200-A F/F NEW COLONY, CHANDAN HOLLA, NEAR PRIMARY SOUTH DELHI South Delhi DL 110074 IN .
What sector does Medansa Pharmaceuticals Private Limited operate in?
Medansa Pharmaceuticals Private Limited operates in the Wholesale Trade sector (NIC code 51100), classified as Non-govt company.
Who are the directors of Medansa Pharmaceuticals Private Limited?
Director details for Medansa Pharmaceuticals Private Limited have not yet been extracted from MGT-7 filings.
What is the paid-up capital of Medansa Pharmaceuticals Private Limited?
Medansa Pharmaceuticals Private Limited has authorized capital of ₹10.00 L and paid-up capital of ₹3.00 L.
Does Medansa Pharmaceuticals Private Limited have any open charges?
Medansa Pharmaceuticals Private Limited has no open MCA-registered charges on record.
What is Medansa Pharmaceuticals Private Limited's Compliance Health Score?
RegisterKaro's Compliance Health Score for Medansa Pharmaceuticals Private Limited is 67/100 (grade C), based on 4 assessable weighted signals across charges, directors, capital, and overall status. 3 of 4 passed — this is a provisional score; full scoring is pending extraction of the company's MCA filing history.